Katoh M - Search Results

1

Functional proteomics of the epigenetic regulators ASXL1, ASXL2 and ASXL3: a convergence of proteomics and epigenetics for translational medicine.

Katoh M. Katoh M. Expert Rev Proteomics. 2015 Jun;12(3):317-28. doi: 10.1586/14789450.2015.1033409. Epub 2015 Apr 3. Expert Rev Proteomics. 2015. PMID: 25835095 Review.

2

Genetic alterations of FGF receptors: an emerging field in clinical cancer diagnostics and therapeutics.

Katoh M. Katoh M. Expert Rev Anticancer Ther. 2010 Sep;10(9):1375-9. doi: 10.1586/era.10.128. Expert Rev Anticancer Ther. 2010. PMID: 20836672

3

Mutation spectra of histone methyltransferases with canonical SET domains and EZH2-targeted therapy.

Katoh M. Katoh M. Epigenomics. 2016 Feb;8(2):285-305. doi: 10.2217/epi.15.89. Epub 2015 Sep 28. Epigenomics. 2016. PMID: 26411517 Review.

4

The integration of genomics testing and functional proteomics in the era of personalized medicine.

Katoh M. Katoh M. Expert Rev Proteomics. 2017 Dec;14(12):1055-1058. doi: 10.1080/14789450.2017.1392245. Epub 2017 Oct 23. Expert Rev Proteomics. 2017. PMID: 29039218 No abstract available.

5

Combination immuno-oncology therapy with immune checkpoint blockers targeting PD-L1, PD-1 or CTLA4 and epigenetic drugs targeting MYC and immune evasion for precision medicine.

Katoh M. Katoh M. J Thorac Dis. 2018 Mar;10(3):1294-1299. doi: 10.21037/jtd.2018.03.62. J Thorac Dis. 2018. PMID: 29708143 Free PMC article. No abstract available.

6

Fibroblast growth factor receptors as treatment targets in clinical oncology.

Katoh M. Katoh M. Nat Rev Clin Oncol. 2019 Feb;16(2):105-122. doi: 10.1038/s41571-018-0115-y. Nat Rev Clin Oncol. 2019. PMID: 30367139 Review.

7

Cardio-miRNAs and onco-miRNAs: circulating miRNA-based diagnostics for non-cancerous and cancerous diseases.

Katoh M. Katoh M. Front Cell Dev Biol. 2014 Oct 16;2:61. doi: 10.3389/fcell.2014.00061. eCollection 2014. Front Cell Dev Biol. 2014. PMID: 25364765 Free PMC article. Review.

8

FGFR inhibitors: Effects on cancer cells, tumor microenvironment and whole-body homeostasis (Review).

Katoh M. Katoh M. Int J Mol Med. 2016 Jul;38(1):3-15. doi: 10.3892/ijmm.2016.2620. Epub 2016 May 31. Int J Mol Med. 2016. PMID: 27245147 Free PMC article. Review.

9

Precision medicine for human cancers with Notch signaling dysregulation (Review).

Katoh M, Katoh M. Katoh M, et al. Int J Mol Med. 2020 Feb;45(2):279-297. doi: 10.3892/ijmm.2019.4418. Epub 2019 Dec 4. Int J Mol Med. 2020. PMID: 31894255 Free PMC article. Review.

10

Genomic Landscape of Experimental Bladder Cancer in Rodents and Its Application to Human Bladder Cancer: Gene Amplification and Potential Overexpression of Cyp2a5/CYP2A6 Are Associated with the Invasive Phenotype.

Kanemoto K, Fukuta K, Kawai N, Tozawa K, Ochiai M, Okamoto K, Ohnami S, Sakamoto H, Yoshida T, Kanai Y, Katoh M, Yasui T, Kohri K, Kakizoe T, Nakagama H. Kanemoto K, et al. Among authors: katoh m. PLoS One. 2016 Nov 30;11(11):e0167374. doi: 10.1371/journal.pone.0167374. eCollection 2016. PLoS One. 2016. PMID: 27902773 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results